Therapeutic Drug Monitoring Market size to Hit USD 3.09 Billion by 2033
Laxman Dige
Brand Builder at Precedence Research | Towards Healthcare | Towards Packaging | Nova One Advisor
According to Nova One Advisor, the global therapeutic drug monitoring market size was exhibited at USD 2.11 billion in 2023 and is projected to hit around USD 3.09 billion by 2033, growing at a CAGR of 3.9% during the forecast period 2024 to 2033.
Recent technological advancements in the Point-of-Care (PoC) devices hold considerable transformative promises for the personalized predictive and preventive medicine. Therapeutic Drug Monitoring (TDM) forms a foundational part to the devising of personalized treatment plans for patients; and the advent of PoC diagnostic devices that yield quantitative measurements of the drug concentration plays a pivotal role in supporting the development of the precision medicine field in the healthcare sector. However, the broad application of the PoC devices for patient monitoring is still lagging behind. The presence of this untapped opportunity is one of the high impact rendering drivers for the market growth.
The employment of continuous therapeutic drug and metabolite monitoring in the early phase of the medication regimen, administered post-organ transplantation, forms a major application in the areas of critical care medicine and organ transplantation, which is expected to propel the growth of the therapeutic drug monitoring market over the forecast period. In addition, the imposing burden of diseases, such as epilepsy and cancer, the rising government initiatives, and the presence of high-unmet needs are some of the crucial determinants expected to further favor the emergence of this market.
Full Report is Ready | Ask here for Sample Copy@? ?https://www.novaoneadvisor.com/report/sample/8831
Therapeutic Drug Monitoring Market Key Takeaways
Immediate Delivery Available, Get Full Access@ ??https://www.novaoneadvisor.com/report/checkout/8831
Therapeutic Drug Monitoring Market By Regional Insights
North America dominated the global therapeutics drugs monitoring market in 2023 with a revenue share of 42.17%. The major factors contributing to the dominance are the population's awareness and government regulations that support the market. For instance, in October 2023, the FDA approved ProciseDx's TDM tests (Procise IFX and Procise ADL) for monitoring infliximab and adalimumab, medications used to treat inflammatory bowel disease (IBD). This is significant for the millions of IBD patients, as these tests help doctors optimize treatment for the 15% who rely on these drugs. The tests are designed for use in hospitals and similar lab settings.
U.S. Therapeutic Drug Monitoring Market Trends
The U.S. dominated the market in the region with a market share of market share of 88.17% in 2023. The dominance can be attributed to the large awareness among the population, the increasing number of drug developments, research, and launches, and the well-established major pharmaceutical players. For instance, in March 2024, Cognizant leveraged generative AI (gen AI) technology through the NVIDIA BioNeMo platform to address intricate drug discovery challenges in the life sciences sector. This initiative aimed to enhance productivity during development and accelerate the introduction of new life-saving treatments to the market.
Europe Therapeutic Drug Monitoring Market Trends
Europe held a significant market share in 2023; this can be attributed to the increasing demand for personalized medicines, and increasing awareness of the benefits of personalized medicine has made the increase in adoption in recent years. For instance, in 2024, Capitainer secured approximately SEK 2 million in funding to expand production capabilities and enhance sales efforts in Europe and the U.S. This investment, led by Sciety and the Sciety Venture Partners network, highlights the strong confidence in Capitainer's innovative technology and its potential to drive advancements in healthcare.
The UK therapeutic drug monitoring market is expected to grow rapidly in the coming years due to advancements in drug monitoring tools. Advancements in therapeutic drug monitoring tools allow for precise monitoring and personalized treatment plans, propelling market growth.
For instance, in July 2023, University College London (UCL) researchers showcased a new drug-monitoring device at the Royal Society Summer Science Exhibition. Developed by a consortium that includes UCL researchers, the ChromaDose device measures cancer medicine levels in a patient's blood to mitigate side effects such as heart problems during chemotherapy for children in the UK. This innovation aims to reduce the occurrence of treatment-related complications, which affect up to 65% of the 10,000 children receiving anti-cancer medications in the UK and will aid doctors in determining personalized treatment doses for future patients.
Germany therapeutics drugs monitoring market is expected to grow rapidly in the coming years due to the awareness is increasing among the people and the participation of major healthcare organization in improving the systems quality and infrastructure
Asia Pacific Therapeutic Drug Monitoring Market Trends
Asia Pacific therapeutics drugs monitoring market is expected to grow at the fastest CAGR of 4.1% over the forecast period. The increasing number of chronic diseases and the increase in the senior population are the major factors contributing to the market growth in the region. According to the WHO, non-communicable diseases (NCDs), Southeast Asia faces a growing threat from non-communicable diseases such as heart disease, cancer, diabetes, and lung issues. These illnesses account for a staggering 62% of deaths in the region, impacting an estimated 9 million people.
China's aging population, rising chronic diseases, and government support are expected to grow its therapeutic drug monitoring market significantly. According to the WHO, China's aging population is exploding, with projections showing that nearly a third (28%) of the population will be over 60 by 2040 due to rising life expectancy and fewer births. This demographic shift brings hurdles and opportunities for public health and economic growth.
India's therapeutics drugs monitoring market is expected to grow significantly over the forecast period due to increasing awareness among the people and the preference for a better healthcare system, which are the major driving factors.
Therapeutic Drug Monitoring Market Top Key Companies:
The following are the leading companies in the therapeutic drug monitoring market. These companies collectively hold the largest market share and dictate industry trends.
Therapeutic Drug Monitoring Market Recent Developments
Therapeutic Drug Monitoring Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the Therapeutic Drug Monitoring market.
领英推荐
By Product?
?
By Drug Class?
By End Use?
By Region
Reasons to Purchase this Report
? Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Immediate Delivery Available | Buy This Premium Research ??https://www.novaoneadvisor.com/report/checkout/8831
Call: USA: +1 650 460 3308 | IND: +91 87933 22019 |Europe: +44 2080772818
Email: [email protected]
You can place an order or ask any questions, please feel free to contact at?[email protected] ?| +1 650 460 3308